Back
Celldex Therapeutics Quote, Financials, Valuation and Earnings
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Buy
65
CLDX
Celldex Therapeutics
Last Price:
43.12
Seasonality Move:
-0.32%
7 Day Trial
ALL ACCESS PASS
$
7
Hope Is Not a Strategy!
Learn MoreCelldex Therapeutics Price Quote
$43.12
-1.04 (-2.36%)
(Updated: September 16, 2024 at 3:50 PM ET)
Celldex Therapeutics Key Stats
Buy
65
Celldex Therapeutics (CLDX)
is a Buy
Day range:
$41.97 - $44.28
52-week range:
$22.11 - $53.18
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
298.17
P/B ratio:
3.6%
Volume:
542.9K
Avg. volume:
627.5K
1-year change:
61.05%
Market cap:
$2.9B
Revenue:
$6.9M
EPS:
$-2.75
How Much Does Celldex Therapeutics Make?
-
How Much Are Celldex Therapeutics's Sales Annually?
CLDX Revenues are $6.9M -
How Much Profit Does Celldex Therapeutics's Make A Year?
CLDX net income is -$141.4M
Is Celldex Therapeutics Growing As A Company?
-
What Is Celldex Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 8.32% -
What Is Celldex Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Celldex Therapeutics Stock Price Performance
-
Did Celldex Therapeutics Stock Go Up Last Month?
Celldex Therapeutics share price went up by 32.69% last month -
Did CLDX's Share Price Rise Over The Last Year?
CLDX share price rose by 61.05% over the past 1 year
What Is Celldex Therapeutics 52-Week High & Low?
-
What Is Celldex Therapeutics’s 52-Week High Share Price?
Celldex Therapeutics has traded as high as $53.18 over the past 52 weeks -
What Is Celldex Therapeutics’s 52-Week Low Share Price?
Celldex Therapeutics has traded as low as $22.11 over the past 52 weeks
Celldex Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Celldex Therapeutics?
-
How Much Debt Does Celldex Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Celldex Therapeutics Have?
Cash and short term investments quarterly total is $802.3M -
What Is Celldex Therapeutics’s Book Value Per Share?
Book value per share is 12.28
Is Celldex Therapeutics Cash Flow Positive?
-
What Is CLDX Cash Flow From Operations?
Cash flow from operations (TTM) is -$121.5M -
What Is Celldex Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $657.5M -
What Is Celldex Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$521.4M
Celldex Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
CLDX return on invested capital is -28.83% -
What Is Celldex Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -27.22% -
What Is CLDX Return On Equity?
ROE is a measure of profitability and is -28.83%
Celldex Therapeutics Earnings Date & Stock Price
-
What Is Celldex Therapeutics's Stock Price Today?
A single share of CLDX can be purchased today for 44.16 -
What Is Celldex Therapeutics’s Stock Symbol?
Celldex Therapeutics trades on the nasdaq under the ticker symbol: CLDX -
When Is Celldex Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Celldex Therapeutics is scheduled on November 1, 2024 -
When Is CLDX's next ex-dividend date?
Celldex Therapeutics's next ex-dividend date is May 16, 2020 -
How To Buy Celldex Therapeutics Stock?
You can buy Celldex Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Celldex Therapeutics Competitors
-
Who Are Celldex Therapeutics's Competitors?
Below is a list of companies who compete with Celldex Therapeutics or are related in some way:
Celldex Therapeutics Dividend Yield
-
What Is CLDX Dividend Yield?
Celldex Therapeutics’s dividend yield currently is 0% -
What Is Celldex Therapeutics’s Payout Ratio?
Celldex Therapeutics’s payout ratio is 0% -
When Did Celldex Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 16, 2024 -
What Is Celldex Therapeutics’s Dividend Per Share?
Celldex Therapeutics pays a dividend of $0.00 per share
Celldex Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 8.99% |
| Revenue: | 832.09% | 192.41% |
Analyst Recommendations
| Buy Recommendations: | 8 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 67.00 |
| Upside from Last Price: | 51.72% |